OBJECTIVE: The impact of glucocorticoids and mineralocorticoids on chronic otitis media (COM) in toll-like receptor 4-deficient C3H/HeJ mice was investigated. STUDY DESIGN: To evaluate control of COM by steroids with differences in their anti-inflammatory (prednisolone, dexamethasone), and fluid absorption functions (fludrocortisone, aldosterone). A minimum sample size of five animals for each group was required based on power analysis calculations. Sample sizes ranged from 7 to 17 mice per treatment group. SUBJECTS AND METHODS: Auditory brain stem response (ABR) thresholds were performed at baseline, 2 weeks and 4 weeks. Histopathologic test results were evaluated on all mice ears at the end of the study. RESULTS: Analysis of variance (ANOVA) of ABR threshold change showed significant treatment effects (P < 0.05) by both steroid types at all time intervals and ABR frequencies except 4 weeks/8 kHz. Histologic assessment showed prednisolone-treated mice (62%) had a higher rate of clearance of middle and inner ear inflammation than control mice (4%). CONCLUSION: It was concluded that steroid treatments can improve the physiology of chronic middle and inner ear disease seen with COM.
OBJECTIVE: The impact of glucocorticoids and mineralocorticoids on chronic otitis media (COM) in toll-like receptor 4-deficient C3H/HeJmice was investigated. STUDY DESIGN: To evaluate control of COM by steroids with differences in their anti-inflammatory (prednisolone, dexamethasone), and fluid absorption functions (fludrocortisone, aldosterone). A minimum sample size of five animals for each group was required based on power analysis calculations. Sample sizes ranged from 7 to 17 mice per treatment group. SUBJECTS AND METHODS: Auditory brain stem response (ABR) thresholds were performed at baseline, 2 weeks and 4 weeks. Histopathologic test results were evaluated on all mice ears at the end of the study. RESULTS: Analysis of variance (ANOVA) of ABR threshold change showed significant treatment effects (P < 0.05) by both steroid types at all time intervals and ABR frequencies except 4 weeks/8 kHz. Histologic assessment showed prednisolone-treated mice (62%) had a higher rate of clearance of middle and inner ear inflammation than control mice (4%). CONCLUSION: It was concluded that steroid treatments can improve the physiology of chronic middle and inner ear disease seen with COM.
Authors: A Ruohola; T Heikkinen; J Jero; T Puhakka; T Juvén; M Närkiö-Mäkelä; H Saxén; O Ruuskanen Journal: J Pediatr Date: 1999-04 Impact factor: 4.406
Authors: Ellen M Mandel; Margaretha L Casselbrant; Howard E Rockette; Philip Fireman; Marcia Kurs-Lasky; Charles D Bluestone Journal: Pediatrics Date: 2002-12 Impact factor: 7.124
Authors: A Poltorak; X He; I Smirnova; M Y Liu; C Van Huffel; X Du; D Birdwell; E Alejos; M Silva; C Galanos; M Freudenberg; P Ricciardi-Castagnoli; B Layton; B Beutler Journal: Science Date: 1998-12-11 Impact factor: 47.728
Authors: Sara A Tokarz; Jiaqing Pang; Anna Grosz; J Beth Kempton; Dennis R Trune; De-Ann M Pillers Journal: Acta Otolaryngol Date: 2013-07 Impact factor: 1.494
Authors: Jessyka G Lighthall; J Beth Kempton; Frances Hausman; Carol J MacArthur; Dennis R Trune Journal: PLoS One Date: 2015-03-26 Impact factor: 3.240
Authors: Jian-Dong Li; Ann Hermansson; Allen F Ryan; Lauren O Bakaletz; Steve D Brown; Michael T Cheeseman; Steven K Juhn; Timothy T K Jung; David J Lim; Jae Hyang Lim; Jizhen Lin; Sung-Kyun Moon; J Christopher Post Journal: Otolaryngol Head Neck Surg Date: 2013-04 Impact factor: 3.497